Patent US4218404A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4218404A Expired / Lapsed US ⏱️ 0.0 years remaining

ω-Aminocarboxylic acid amides

Assignee: Chinoin Private Co Ltd
•
Filing: 1978-03-08
•
Granted: 1980-08-19
•
Expires: 1998-03-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to novel ω-aminocarboxylic acid amides having the formula (I) ##STR1## wherein A is --SO 2 OH or --OPO(OH) 2 , R 1 is hydrogen, an acyl group, such as benzoyl, arylsulfonyl, alkoxycarbonyl, cycloalkoxycarbonyl or aralkoxycarbonyl group or an aralkoxycarbonyl group having a halogen, alkoxy, nitro, phenylazo or alkoxyphenylazo substituent, alkyl-substituted aryloxycarbonyl or carbonyl, R 2 is hydrogen or a carbonyl group, with the proviso that when R 1 and R 2 each stand for carbonyl, the two carbonyl groups form a ring through an intervening o-phenylene, alkylene or vinylene group when A is --SO 2 OH and R 1 is an acyl group such as benzoyl, aryl sulfonyl, alkoxy-carbonyl, cycloalkoxycarbonyl or aryloxycarbonyl group or an aralkoxy carbonyl group having a halogen, alkoxy, nitro, phenylozo or alkoxyphenylazo substituent or an alkyl-substituted aryloxycarbonyl group or carbonyl group, R 2 is hydrogen or a carbonyl group, with the proviso that when R 1 and R 2 each stand for carbonyl, the two carbonyl groups form a ring through an intervening o-phenylene, alkylene or vinylene group when A is --O--P--O(OH) 2 and n is equal to 2 or 3, and salts of the above compounds, furthermore to a process for the preparation thereof. The novel compounds according to the invention possess valuable pharmacological effects in reducing blood sugar levels or can be applied as intermediate in the synthesis of biologically active compounds.

Inventors

  • 👤 Laszlo Feuer
  • 👤 Arpad Furka
  • 👤 Ferenc Sebestyen
  • 👤 Aniko Horvath
  • 👤 nee Szepespataki Jolan Hercsel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 22:35
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/08; C07F9/09; C07F9/091

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 28 words
A compound selected from the group consisting of: N-acetyl-γ-aminobutyryl-taurine; N-benzoyl-γ-aminobutyryl-taurine; γ-aminobutyryl-homotaurine; β-alanyl-homotaurine; N-carbobenzoxy-γ-aminobutyryl-homotaurine; N-carbobenzoxy-γ-aminobutyryl-ethanolamine phosphate; N-carbobenzoxy-γ-aminobutyryl-propanolamine phosphate; N-carbobenzoxy-β-alanyl-ethanolamine phosphate; and N-carbobenzoxy-β-alanyl-propanolamine phosphate; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 28 words
A compound selected from the group consisting of: N-acetyl-γ-aminobutyryl-taurine; N-benzoyl-γ-aminobutyryl-taurine; γ-aminobutyryl-homotaurine; β-alanyl-homotaurine; N-carbobenzoxy-γ-aminobutyryl-homotaurine; N-carbobenzoxy-γ-aminobutyryl-ethanolamine phosphate; N-carbobenzoxy-γ-aminobutyryl-propanolamine phosphate; N-carbobenzoxy-β-alanyl-ethanolamine phosphate; and N-carbobenzoxy-β-alanyl-propanolamine phosphate; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 32 words
A compound of the formula: ##STR10## wherein A is --OPO(OH) 2 ; R 1 is carbobenzoxy; R 2 is hydrogen; and n is 2 or 3; or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 32 words
A compound of the formula: ##STR10## wherein A is --OPO(OH) 2 ; R 1 is carbobenzoxy; R 2 is hydrogen; and n is 2 or 3; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 61 words
A compound of the formula: ##STR11## wherein A is --SO 2 OH; n is 2 or 3; R 2 is hydrogen; and R 1 is acetyl or benzoyl; or of the formula: ##STR12## wherein A is --SO 2 OH; n is 2 or 3; R 2 is hydrogen; and R 1 is hydrogen or carbobenzoxy; or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim 61 words
A compound of the formula: ##STR11## wherein A is --SO 2 OH; n is 2 or 3; R 2 is hydrogen; and R 1 is acetyl or benzoyl; or of the formula: ##STR12## wherein A is --SO 2 OH; n is 2 or 3; R 2 is hydrogen; and R 1 is hydrogen or carbobenzoxy; or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 34 words
A compound of the formula: ##STR13## wherein A is --SO 2 OH; R 1 is acetyl or benzoyl; R 2 is hydrogen; and n is 2 or 3; or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 34 words
A compound of the formula: ##STR13## wherein A is --SO 2 OH; R 1 is acetyl or benzoyl; R 2 is hydrogen; and n is 2 or 3; or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 8 words
N-Carbobenzoxy-γ-aminobutyryl-ethanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim 8 words
N-Carbobenzoxy-γ-aminobutyryl-ethanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim 8 words
N-Carbobenzoxy-γ-aminobutyryl-propanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 8 words
N-Carbobenzoxy-γ-aminobutyryl-propanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim 8 words
N-Carbobenzoxy-β-alanyl-ethanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 14
Dependent Claim 8 words
N-Carbobenzoxy-β-alanyl-ethanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 15
Dependent Claim 8 words
N-Carbobenzoxy-β-alanyl-propanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 16
Dependent Claim 8 words
N-Carbobenzoxy-β-alanyl-propanolamine phosphate or a pharmaceutically acceptable salt thereof.
Claim 17
Dependent Claim 7 words
N-Acetyl-γ-aminobutyryl-taurine or a pharmaceutically acceptable salt thereof.
Claim 18
Dependent Claim 7 words
N-Acetyl-γ-aminobutyryl-taurine or a pharmaceutically acceptable salt thereof.
Claim 19
Dependent Claim 7 words
N-Benzoyl-γ-aminobutyryl-taurine or a pharmaceutically acceptable salt thereof.
Claim 20
Dependent Claim 7 words
N-Benzoyl-γ-aminobutyryl-taurine or a pharmaceutically acceptable salt thereof.
Claim 21
Dependent Claim 7 words
γ-Aminobutyryl-homotaurine or a pharmaceutically acceptable salt thereof.
Claim 22
Dependent Claim 7 words
γ-Aminobutyryl-homotaurine or a pharmaceutically acceptable salt thereof.
Claim 23
Dependent Claim 7 words
N-Carbobenzoxy-γ-aminobutyryl-homotaurine or a pharmaceutically acceptable salt thereof.
Claim 24
Dependent Claim 7 words
N-Carbobenzoxy-γ-aminobutyryl-homotaurine or a pharmaceutically acceptable salt thereof.
Claim 25
Dependent Claim 7 words
β-alanyl-homotaurine or a pharmaceutically acceptable salt thereof.
Claim 26
Dependent Claim 7 words
β-alanyl-homotaurine or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US1485377A Cited
DE1954090A1 Cited
US4102948A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-08-19 1984-02-18 1984-08-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-08-19 1988-02-18 1988-08-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-08-19 1992-02-18 1992-08-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag